Vestal Point Capital »

Soleno Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $49M 1.2M 40.80

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Perceptive Advisors
Nantahala Capital Management
BlackRock
Vanguard Group
Commodore Capital
Vestal Point Capital
State Street Corporation
Frazier Life Sciences Management
Sofinnova Ventures
Holocene Advisors
Samlyn Capital
Geode Capital Management
Millennium Management

View all funds holding Soleno Therapeutics